| pubmed-article:20833076 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20833076 | lifeskim:mentions | umls-concept:C0311400 | lld:lifeskim |
| pubmed-article:20833076 | lifeskim:mentions | umls-concept:C0268731 | lld:lifeskim |
| pubmed-article:20833076 | lifeskim:mentions | umls-concept:C1519104 | lld:lifeskim |
| pubmed-article:20833076 | lifeskim:mentions | umls-concept:C0220825 | lld:lifeskim |
| pubmed-article:20833076 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:20833076 | pubmed:dateCreated | 2011-6-20 | lld:pubmed |
| pubmed-article:20833076 | pubmed:abstractText | Insulin resistance is a common metabolic abnormality, which increases the risk of renal events in obesity. The present study is aimed to examine the relation between metabolic factors and obesity-related glomerulopathy (ORG), and then compare the risk markers of insulin resistance for clinical prediction. | lld:pubmed |
| pubmed-article:20833076 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20833076 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20833076 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20833076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20833076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20833076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20833076 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20833076 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20833076 | pubmed:month | Jul | lld:pubmed |
| pubmed-article:20833076 | pubmed:issn | 1532-8503 | lld:pubmed |
| pubmed-article:20833076 | pubmed:author | pubmed-author:DaleT JTJ | lld:pubmed |
| pubmed-article:20833076 | pubmed:author | pubmed-author:LiuZhi-HongZH | lld:pubmed |
| pubmed-article:20833076 | pubmed:author | pubmed-author:LiLei-ShiLS | lld:pubmed |
| pubmed-article:20833076 | pubmed:author | pubmed-author:ChenHui-PingH... | lld:pubmed |
| pubmed-article:20833076 | pubmed:author | pubmed-author:WangQing-WenQ... | lld:pubmed |
| pubmed-article:20833076 | pubmed:author | pubmed-author:ChenHui-MeiHM | lld:pubmed |
| pubmed-article:20833076 | pubmed:author | pubmed-author:ZhangPei-PeiP... | lld:pubmed |
| pubmed-article:20833076 | pubmed:author | pubmed-author:ZhangYi-DeYD | lld:pubmed |
| pubmed-article:20833076 | pubmed:copyrightInfo | Copyright © 2011 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved. | lld:pubmed |
| pubmed-article:20833076 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:20833076 | pubmed:volume | 21 | lld:pubmed |
| pubmed-article:20833076 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20833076 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20833076 | pubmed:pagination | 309-15 | lld:pubmed |
| pubmed-article:20833076 | pubmed:dateRevised | 2011-11-17 | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:meshHeading | pubmed-meshheading:20833076... | lld:pubmed |
| pubmed-article:20833076 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:20833076 | pubmed:articleTitle | Evaluation of metabolic risk marker in obesity-related glomerulopathy. | lld:pubmed |
| pubmed-article:20833076 | pubmed:affiliation | Research Institute of Nephrology, Jinling Hospital, Nanjing University School of Medicine, Nanjing 210002, People's Republic of China. | lld:pubmed |
| pubmed-article:20833076 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20833076 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
